©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: DEA
Turning Tides? DEA Seeking Fewer Opioids; Increase in Cannabis for Research
WASHINGTON, D.C. – The U.S. Drug Enforcement Administration (DEA) is seeking to lower opioid medication production levels next year while increasing production of cannabis...
DEA Again Announces Intention to Process Cannabis Research Applications
WASHINGTON, D.C. – Although cannabis consumption has been rapidly increasing in recent years, formal research into the benefits and risks of the plant are lagging...
Curaleaf Issues Response to FDA Letter
WAKEFIELD, Mass. – Curaleaf has responded to a letter the company received from the Food and Drug Administration (FDA). The agency has accused the...
Review: “Weed the People” Shows Struggles, Successes of Cannabis Meds for Cancer
Now available on Netflix, 2018 documentary “Weed the People,” follows the stories of several young cancer patients—Sophie, Cecilia, AJ, and Chico, who ranged in...
‘Hemp is Legal’ Challenges Facebook Ad Policy
PHOENIX, Ariz. – Nonprofit trade group Hemp Industries Association, has partnered with cannabis industry stakeholders Hoban Law Group, CBD product company Bluebird Botanicals, and...
FDA, FTC Take Action on CBD-Infused Products Prior to Public Comments
WASHINGTON, D.C.–Action by the Food and Drug Administration (FDA) on the regulation of CBD-infused products seems imminent, after recent events may signal new developments...
U.S. Surgeon General Said Cannabis’ Medical Potential Should be Studied
BOSTON–The Washington Post interviewed U.S. Surgeon General Jerome Adams in early December, resulting in a video post entitled “Tackling the Opioid Crisis: The Federal...
Farm Bill Means CBD is Legal? Producer Receives Letter That Could Indicate Otherwise
PHOENIX- Passage of the farm bill at the end of last year provided a feel-good story for the cannabis industry. Initially, it seemed to...
FDA Coming Around on CBD?
WASHINGTON, D.C.- The Food and Drug Administration (FDA) appears to be softening its stance on CBD.
In June, the FDA approved Epiodolex, a CBD based...
DEA Classifies CBD-based Epidiolex as Schedule V Controlled Substance
WASHINGTON, D.C. – On Friday, the United States Drug Enforcement Administration is expected to issue a final order placing Epidiolex on Schedule V of the Controlled...